10-YEAR FOLLOW-UP OF PATIENTS WITH POOR PROGNOSIS GERM CELL TUMOR TREATED WITH FIRST-LINE LATE-INTENSIFICATION HIGH-DOSE CHEMOTHERAPY

被引：0
|
作者：
Papiani, Giorgio [1 ]
De Giorgi, Ugo [1 ]
Marangolo, Maurizio [1 ]
Rosti, Giovanni [1 ]
机构：
[1] Santa Maria delle Croci Hosp, Dept Hematol Oncol, Ravenna, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [41] A 10-year follow-up of high-dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease
    Hwang, Soojin
    Bae, Hyunwoo
    Yoon, Ji-Hee
    Kim, Dohyung
    Do, Hyo-Sang
    Heo, Sun Hee
    Kim, Soyoung
    Yoo, Han-Wook
    Istaiti, Majdolen
    Zimran, Ari
    Lee, Beom Hee
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1396 - 1399
  • [42] Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study
    Leng, X. M.
    Jiang, Y.
    Zhou, D. B.
    Tian, X. P.
    Li, T. S.
    Wang, S. J.
    Zhao, Y. Q.
    Shen, T.
    Zeng, X. F.
    Zhang, F. C.
    Tang, F. L.
    Dong, Y.
    Zhao, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (03) : 494 - 499
  • [43] High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
    Motzer, RJ
    Mazumdar, M
    Bajorin, DF
    Bosl, GJ
    Lyn, P
    Vlamis, V
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2546 - 2552
  • [44] High DNA damage levels to predict hematologic toxicity in testicular germ cell tumor (TGCT) patients treated with first-line chemotherapy.
    Mego, Michal
    Hapakova, Nikola
    Sestakova, Zuzana
    Holickova, Andrea
    Miskovska, Vera
    Chovanec, Michal
    Rejlekova, Katarina
    Svetlovska, Daniela
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    De Angelis, Valentina
    Sycova, Zuzana
    Mardiak, Jozef
    Chovanec, Miroslav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: Evaluation of a prognostic score for survival after high-dose chemotherapy
    Sammler, C.
    Beyer, J.
    Bokemeyer, C.
    Hartmann, J. T.
    Rick, O.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (02) : 237 - 243
  • [46] High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity
    Decatris, MP
    Wilkinson, PM
    Welch, RS
    Metzner, M
    Morgenstern, GR
    Dougall, M
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 427 - 434
  • [47] Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor
    Miki, Tsuneharu
    Mizutani, Yoichi
    Akaza, Hideyuki
    Ozono, Seiichiro
    Tsukamoto, Taiji
    Terachi, Toshiro
    Naito, Katsusuke
    Nonomura, Norio
    Hara, Isao
    Yoshida, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (01) : 54 - 59
  • [48] High-dose chemotherapy and autologous hemopoietic stem cell transplantation in patients with poor-prognosis germ cell tumors - single center experience
    Sarosiek, T
    Zolnierek, J
    Langiewicz, P
    Lesniewski-Kmak, K
    Szczylik, C
    Rzepecki, P
    Jedrzejczak, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S192 - S193
  • [49] The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
    Houssiau, F. A.
    Vasconcelos, C.
    D'Cruz, D.
    Sebastiani, G. D.
    de Ramon Garrido, E.
    Danieli, M. G.
    Abramovicz, D.
    Blockmans, D.
    Cauli, A.
    Direskeneli, H.
    Galeazzi, M.
    Gul, A.
    Levy, Y.
    Petera, P.
    Popovic, R.
    Petrovic, R.
    Sinico, R. A.
    Cattaneo, R.
    Font, J.
    Depresseux, G.
    Cosyns, J-P
    Cervera, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 61 - 64
  • [50] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS
    BARNETT, MJ
    COPPIN, CML
    MURRAY, N
    NEVILL, TJ
    REECE, DE
    KLINGEMANN, HG
    SHEPHERD, JD
    NANTEL, SH
    SUTHERLAND, HJ
    PHILLIPS, GL
    BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 594 - 598
12345